Flexion Therapeutics Inc. (FLXN) NASDAQ

$9.12 -0.02 (-0.22%)

Market Cap: $0

As of 11/18/21 04:00 PM EST. Market closed.

(FLXN)

Flexion Therapeutics Inc. (FLXN) NASDAQ

$9.12 -0.02 (-0.22%)

Market Cap: $0

As of 11/18/21 04:00 PM EST. Market closed.

Flexion Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company's core values are focus, ingenuity, tenacity, transparency and ... read more

Flexion Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company's core values are focus, ingenuity, tenacity, transparency and fun. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Michael Clayman
Full Time Employees
257
CEO Compensation (Base)
$600,000
CEO Compensation (Total)
$3.22M
URL
Address
10 Mall Rd Ste 301, Massachusetts, Burlington, 01803-4131.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Michael Clayman
Full Time Employees
257
CEO Compensation (Base)
$600,000
CEO Compensation (Total)
$3.22M
Address
10 Mall Rd Ste 301, Massachusetts, Burlington, 01803-4131.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
KEY STATS
Open
$9.19
Previous Close
$9.14
Days Range
$9.12 - $9.23
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
50,321,366
Open
$9.19
Previous Close
$9.14
Days Range
$9.12 - $9.23
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
50,321,366

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR FLEXION THERAPEUTICS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Stejbach Mark Director Nov 19, 2021 Option Exercise $8.50 12,631 107,364 0 Nov 19, 2021, 10:20 AM
MILINAZZO ALAN Director Nov 19, 2021 Option Exercise $8.50 27,450 233,325 0 Nov 19, 2021, 10:19 AM
MERRIFIELD C ANN Director Nov 19, 2021 Option Exercise $8.50 19,000 161,500 0 Nov 19, 2021, 10:17 AM
Lukatch Heath Director Nov 19, 2021 Option Exercise $8.50 9,000 76,500 0 Nov 19, 2021, 10:16 AM
Kwo Elizabeth Director Nov 19, 2021 Option Exercise $8.50 4,500 38,250 0 Nov 19, 2021, 10:14 AM
COLELLA SAMUEL D Director Nov 19, 2021 Option Exercise $8.50 943 8,016 0 Nov 19, 2021, 10:12 AM
COLELLA SAMUEL D Director Nov 19, 2021 Option Exercise $8.50 1,000 8,500 0 Nov 19, 2021, 10:12 AM
COLELLA SAMUEL D Director Nov 19, 2021 Option Exercise $8.50 388,683 3,303,806 0 Nov 19, 2021, 10:12 AM
COLELLA SAMUEL D Director Nov 19, 2021 Option Exercise $8.50 9,000 76,500 0 Nov 19, 2021, 10:12 AM
COLELLA SAMUEL D Director Nov 19, 2021 Option Exercise $8.50 5,871 49,904 0 Nov 19, 2021, 10:12 AM
COLELLA SAMUEL D Director Nov 19, 2021 Option Exercise $8.50 994,129 8,450,097 0 Nov 19, 2021, 10:12 AM
COLELLA SAMUEL D Director Nov 19, 2021 Option Exercise $8.50 250 2,125 0 Nov 19, 2021, 10:12 AM
COLELLA SAMUEL D Director Nov 19, 2021 Option Exercise $8.50 5,000 42,500 0 Nov 19, 2021, 10:12 AM
COLELLA SAMUEL D Director Nov 19, 2021 Option Exercise $8.50 19,653 167,051 0 Nov 19, 2021, 10:12 AM
COLELLA SAMUEL D Director Nov 19, 2021 Option Exercise $8.50 72,035 612,298 0 Nov 19, 2021, 10:12 AM
Canute Scott A Director Nov 19, 2021 Option Exercise $8.50 9,000 76,500 0 Nov 19, 2021, 10:10 AM
MAHAFFY PATRICK J Director Nov 19, 2021 Option Exercise $8.50 39,824 338,504 0 Nov 19, 2021, 10:09 AM
Levine Mark S. General Counsel Nov 19, 2021 Option Exercise $8.50 133,486 1,134,631 0 Nov 19, 2021, 10:08 AM
Muzikant Adam Chief Business Officer Nov 19, 2021 Option Exercise $8.50 103,666 881,161 0 Nov 19, 2021, 10:06 AM
Wentworth Kerry Chief Regulatory Officer Nov 19, 2021 Option Exercise $8.50 6,000 51,000 0 Nov 19, 2021, 10:04 AM
Wentworth Kerry Chief Regulatory Officer Nov 19, 2021 Option Exercise $8.50 140,843 1,197,166 0 Nov 19, 2021, 10:04 AM
Layman Melissa Chief Commercial Officer Nov 19, 2021 Option Exercise $8.50 103,956 883,626 0 Nov 19, 2021, 10:03 AM
Willwerth Christina Chief Strategy Officer Nov 19, 2021 Option Exercise $8.50 141,241 1,200,549 0 Nov 19, 2021, 10:01 AM
DRISCOLL FREDERICK W Chief Financial Officer Nov 19, 2021 Option Exercise $8.50 30,680 260,780 0 Nov 19, 2021, 10:00 AM
Andrews William T. Chief Medical Officer Nov 19, 2021 Option Exercise $8.50 34,250 291,125 0 Nov 19, 2021, 09:58 AM
Clayman Michael D. President and CEO Nov 19, 2021 Option Exercise $8.50 24,600 209,100 0 Nov 19, 2021, 09:56 AM
Clayman Michael D. President and CEO Nov 19, 2021 Option Exercise $8.50 373,769 3,177,037 0 Nov 19, 2021, 09:56 AM
Clayman Michael D. President and CEO Nov 19, 2021 Option Exercise $8.50 335,498 2,851,733 0 Nov 19, 2021, 09:56 AM
Clayman Michael D. President and CEO Nov 19, 2021 Option Exercise $8.50 388,683 3,303,806 0 Nov 19, 2021, 09:56 AM
Willwerth Christina Chief Strategy Officer Jul 19, 2021 Sale $6.45 3,945 25,445 141,241 Jul 20, 2021, 08:51 PM
Wentworth Kerry Chief Regulatory Officer Jul 19, 2021 Sale $6.45 3,944 25,439 140,362 Jul 20, 2021, 08:49 PM
Muzikant Adam Chief Business Officer Jul 19, 2021 Sale $6.45 1,870 12,061 103,666 Jul 20, 2021, 08:48 PM
Levine Mark S. General Counsel Jul 19, 2021 Sale $6.45 3,945 25,445 133,486 Jul 20, 2021, 08:45 PM
Muzikant Adam Chief Business Officer Jun 21, 2021 Option Exercise $7.78 2,081 16,190 105,536 Jun 28, 2021, 06:13 PM
Wentworth Kerry Chief Regulatory Officer Jun 21, 2021 Option Exercise $7.78 539 4,193 144,306 Jun 28, 2021, 06:09 PM
Clayman Michael D. President and CEO Jun 21, 2021 Option Exercise $7.78 1,700 13,226 348,840 Jun 28, 2021, 06:04 PM
Arkowitz David Chief Financial Officer May 10, 2021 Sale $7.23 2,229 16,116 220,719 May 12, 2021, 05:06 PM
Layman Melissa Chief Commercial Officer Mar 15, 2021 Sale $11.80 4,520 53,336 103,956 Mar 16, 2021, 05:11 PM
Layman Melissa Chief Commercial Officer Jan 28, 2021 Sale $12.55 2,624 32,931 88,376 Jan 29, 2021, 08:19 PM
Clayman Michael D. President and CEO Jan 28, 2021 Option Exercise $12.37 8,776 108,559 266,901 Jan 29, 2021, 08:17 PM
Muzikant Adam Chief Business Officer Jan 05, 2021 Sale $11.13 4,005 44,576 73,455 Jan 07, 2021, 06:02 PM
KELLEY SCOTT Chief Medical Officer Jan 05, 2021 Sale $11.13 6,829 76,007 113,549 Jan 07, 2021, 05:58 PM
Wentworth Kerry Chief Regulatory Officer Jan 05, 2021 Sale $11.13 6,829 76,007 113,767 Jan 07, 2021, 05:56 PM
Willwerth Christina Chief Strategy Officer Jan 05, 2021 Sale $11.13 6,602 73,480 115,186 Jan 07, 2021, 05:55 PM
Levine Mark S. General Counsel Jan 05, 2021 Sale $11.13 6,829 76,007 107,431 Jan 07, 2021, 05:52 PM
Arkowitz David Chief Financial Officer Jan 05, 2021 Sale $11.13 6,073 67,592 151,048 Jan 07, 2021, 05:50 PM
MILINAZZO ALAN Director Jul 09, 2020 Option Exercise $2.20 18,450 40,500 22,950 Jul 10, 2020, 04:06 PM
Arkowitz David Chief Financial Officer Jun 22, 2020 Option Exercise $10.83 1,303 14,111 118,371 Jun 24, 2020, 04:21 PM
Clayman Michael D. President and CEO Jun 22, 2020 Option Exercise $10.83 1,303 14,111 66,260 Jun 24, 2020, 04:18 PM
KELLEY SCOTT Chief Medical Officer Jun 22, 2020 Option Exercise $10.83 595 6,444 80,960 Jun 24, 2020, 04:15 PM
Levine Mark S. General Counsel Jun 22, 2020 Option Exercise $10.83 1,023 11,079 75,510 Jun 24, 2020, 04:12 PM
Wentworth Kerry Chief Regulatory Officer Jun 22, 2020 Option Exercise $10.83 369 3,996 81,430 Jun 24, 2020, 04:09 PM
Stejbach Mark Director May 26, 2020 Buy $9.75 2,051 19,997 2,051 May 27, 2020, 04:14 PM
Clayman Michael D. President and CEO May 26, 2020 Buy $9.75 10,256 99,996 346,605 May 27, 2020, 04:11 PM
Arkowitz David Chief Financial Officer May 07, 2020 Sale $10.88 2,413 26,253 117,068 May 11, 2020, 04:11 PM
Willwerth Christina Chief Strategy Officer Oct 07, 2019 Option Exercise $13.98 1,002 14,008 66,167 Oct 08, 2019, 04:29 PM
Wentworth Kerry Chief Regulatory Officer Oct 07, 2019 Option Exercise $13.98 1,002 14,008 53,394 Oct 08, 2019, 04:27 PM
Clayman Michael D. President and CEO Oct 07, 2019 Option Exercise $13.98 4,402 61,540 82,647 Oct 08, 2019, 04:25 PM
KELLEY SCOTT Chief Medical Officer Oct 07, 2019 Option Exercise $13.98 334 4,669 53,089 Oct 08, 2019, 04:21 PM
Bodick Neil Chief Scientific Officer Oct 07, 2019 Option Exercise $13.98 1,346 18,817 104,004 Oct 08, 2019, 04:19 PM
MAHAFFY PATRICK J Director Aug 29, 2019 Option Exercise $0.16 30,824 4,932 30,824 Aug 29, 2019, 04:46 PM
Willwerth Christina Chief Strategy Officer Aug 13, 2019 Option Exercise $0.16 8,750 1,400 67,169 Aug 14, 2019, 04:06 PM
COLELLA SAMUEL D Director Aug 08, 2019 Buy $10.74 2,000 21,480 45,333 Aug 09, 2019, 04:05 PM
Clayman Michael D. President and CEO Aug 08, 2019 Buy $10.85 2,317 25,136 72,249 Aug 08, 2019, 04:38 PM
Clayman Michael D. President and CEO Jun 21, 2019 Option Exercise $9.81 1,492 14,637 71,424 Jun 24, 2019, 05:23 PM
Levine Mark S. General Counsel Jun 21, 2019 Option Exercise $9.81 1,213 11,900 46,273 Jun 24, 2019, 04:14 PM
Wentworth Kerry Chief Regulatory Officer Jun 21, 2019 Option Exercise $9.81 389 3,816 50,996 Jun 24, 2019, 04:13 PM
KELLEY SCOTT Chief Medical Officer Jun 21, 2019 Option Exercise $9.81 2,152 21,111 53,423 Jun 24, 2019, 04:11 PM
Arkowitz David Chief Financial Officer Jun 21, 2019 Option Exercise $9.81 2,152 21,111 91,576 Jun 24, 2019, 04:10 PM
Arkowitz David Chief Financial Officer May 31, 2019 Buy $11.05 2,500 27,627 89,424 Jun 03, 2019, 04:18 PM
MERRIFIELD C ANN Director May 23, 2019 Buy $12.64 8,000 101,120 10,000 May 24, 2019, 09:15 AM
Arkowitz David Chief Financial Officer May 13, 2019 Buy $11.99 4,000 47,960 86,924 May 15, 2019, 04:05 PM
Clayman Michael D. President and CEO May 10, 2019 Buy $12.48 4,012 50,067 74,868 May 13, 2019, 09:15 AM
Arkowitz David Chief Financial Officer May 08, 2019 Sale $10.06 2,248 22,615 82,924 May 09, 2019, 04:32 PM
Clayman Michael D. President and CEO Mar 12, 2019 Buy $12.36 4,046 50,009 70,856 Mar 13, 2019, 04:11 PM
Wentworth Kerry Chief Regulatory Officer Oct 08, 2018 Option Exercise $18.60 1,002 18,637 14,876 Mar 05, 2019, 08:17 PM
Levine Mark S. General Counsel Jan 03, 2019 Sale $12.36 734 9,072 9,060 Jan 04, 2019, 05:12 PM
Wentworth Kerry Chief Regulatory Officer Jan 03, 2019 Sale $12.36 622 7,688 11,207 Jan 04, 2019, 05:10 PM
KELLEY SCOTT Chief Medical Officer Jan 03, 2019 Sale $12.36 622 7,688 15,271 Jan 04, 2019, 05:09 PM
Arkowitz David Chief Financial Officer Dec 20, 2018 Option Exercise $10.48 922 9,663 49,172 Jan 04, 2019, 05:07 PM
Bodick Neil Chief Scientific Officer Jan 03, 2019 Sale $12.36 746 9,221 64,782 Jan 04, 2019, 05:06 PM
Clayman Michael D. President and CEO Jan 03, 2019 Sale $12.36 3,278 40,516 66,810 Jan 04, 2019, 05:03 PM
Clayman Michael D. President and CEO Nov 09, 2018 Buy $17.10 5,000 85,477 69,166 Nov 13, 2018, 09:17 AM
Arkowitz David Chief Financial Officer Nov 09, 2018 Buy $16.56 4,000 66,222 48,250 Nov 13, 2018, 09:14 AM
Bodick Neil Chief Scientific Officer Oct 08, 2018 Option Exercise $18.60 1,345 25,017 65,528 Oct 09, 2018, 05:08 PM
Clayman Michael D. President and CEO Oct 08, 2018 Option Exercise $18.60 6,233 115,934 83,849 Oct 09, 2018, 04:31 PM
Wentworth Kerry Chief Regulatory Officer Oct 08, 2018 Option Exercise $18.60 1,002 18,637 11,476 Oct 09, 2018, 04:30 PM
Arkowitz David Chief Financial Officer Aug 09, 2018 Buy $23.42 4,000 93,680 44,250 Aug 10, 2018, 12:56 PM
Clayman Michael D. President and CEO Aug 09, 2018 Buy $22.33 10,000 223,300 75,282 Aug 10, 2018, 09:13 AM
Bodick Neil Chief Scientific Officer Jul 03, 2018 Sale $25.00 16,492 412,300 62,307 Jul 03, 2018, 12:00 AM
Bodick Neil Chief Scientific Officer Jul 02, 2018 Sale $25.10 33,508 841,192 78,799 Jul 03, 2018, 12:00 AM
Wentworth Kerry Chief Regulatory Officer Jun 20, 2018 Option Exercise $21.22 171 3,629 12,478 Jun 22, 2018, 04:37 PM
KELLEY SCOTT Chief Medical Officer Jun 20, 2018 Option Exercise $21.22 1,001 21,241 15,893 Jun 22, 2018, 04:35 PM
Clayman Michael D. President and CEO Jun 20, 2018 Option Exercise $21.22 554 11,756 65,282 Jun 22, 2018, 04:33 PM
Levine Mark S. General Counsel Jun 20, 2018 Option Exercise $21.22 539 11,438 8,872 Jun 22, 2018, 04:30 PM
Bodick Neil Chief Scientific Officer May 11, 2018 Option Exercise $0.16 37,702 6,130 112,307 May 11, 2018, 04:07 PM
Clayman Michael D. President and CEO Dec 20, 2017 Option Exercise $16.59 166 2,754 35,561 Dec 22, 2017, 05:05 PM
KELLEY SCOTT Chief Medical Officer Dec 20, 2017 Option Exercise $16.59 858 14,234 6,559 Dec 22, 2017, 04:59 PM
Bodick Neil Chief Scientific Officer Nov 21, 2017 Buy $24.66 1,000 24,656 1,000 Nov 22, 2017, 05:28 PM
Bodick Neil Chief Scientific Officer Nov 21, 2017 Buy $24.39 1,700 41,457 64,605 Nov 22, 2017, 05:28 PM
Clayman Michael D. President and CEO Nov 08, 2017 Buy $23.60 5,000 118,000 35,395 Nov 09, 2017, 09:13 AM
Bodick Neil Chief Scientific Officer Oct 06, 2017 Option Exercise $29.93 1,598 47,835 62,905 Oct 10, 2017, 04:43 PM
Clayman Michael D. President and CEO Oct 06, 2017 Option Exercise $29.93 5,794 173,443 30,395 Oct 10, 2017, 04:39 PM
Deniz Yamo Chief Medical Officer Sep 05, 2017 Buy $24.20 1,000 24,200 9,000 Sep 15, 2017, 05:12 PM
Deniz Yamo Chief Medical Officer Sep 01, 2017 Buy $24.15 3,000 72,450 8,000 Sep 15, 2017, 05:12 PM
Deniz Yamo Chief Medical Officer Aug 31, 2017 Buy $25.40 1,375 34,925 5,000 Sep 15, 2017, 05:12 PM
Clayman Michael D. President and CEO Jun 20, 2017 Option Exercise $15.37 1,243 19,105 21,389 Jun 23, 2017, 06:36 PM
Stejbach Mark Director Jun 16, 2017 Buy $17.02 1,580 26,888 1,580 Jun 20, 2017, 04:24 PM
COLELLA SAMUEL D Director Jun 05, 2017 Buy $17.01 5,000 85,048 5,000 Jun 06, 2017, 06:49 PM
Clayman Michael D. President and CEO Jun 05, 2017 Buy $17.23 5,000 86,152 20,146 Jun 06, 2017, 06:47 PM
Bodick Neil Chief Medical Officer May 15, 2017 Option Exercise $2.52 6,830 17,214 66,767 May 19, 2017, 04:34 PM
Bodick Neil Chief Medical Officer May 15, 2017 Sale $18.95 6,830 129,448 61,637 May 19, 2017, 04:34 PM
Bodick Neil Chief Medical Officer Apr 17, 2017 Option Exercise $2.52 5,000 12,601 64,937 May 19, 2017, 04:32 PM
Bodick Neil Chief Medical Officer Apr 17, 2017 Sale $28.23 5,000 141,132 60,137 May 19, 2017, 04:32 PM
Bodick Neil Chief Medical Officer Mar 17, 2017 Option Exercise $2.52 5,000 12,601 64,937 May 19, 2017, 04:31 PM
Bodick Neil Chief Medical Officer Mar 17, 2017 Sale $20.41 5,000 102,038 59,937 May 19, 2017, 04:31 PM
Bodick Neil Chief Medical Officer Feb 24, 2017 Option Exercise $2.52 4,000 10,081 64,937 May 19, 2017, 04:28 PM
Bodick Neil Chief Medical Officer Feb 24, 2017 Sale $19.15 5,000 95,758 59,937 May 19, 2017, 04:28 PM
Bodick Neil Chief Medical Officer May 15, 2017 Sale $18.95 6,830 129,448 40,807 May 17, 2017, 04:15 PM
Bodick Neil Chief Medical Officer Apr 17, 2017 Sale $28.23 5,000 141,132 46,137 Apr 18, 2017, 07:45 PM
DRISCOLL FREDERICK W Chief Financial Officer Mar 23, 2017 Option Exercise $7.89 3,000 23,658 10,777 Mar 24, 2017, 04:24 PM
DRISCOLL FREDERICK W Chief Financial Officer Mar 23, 2017 Sale $23.00 3,000 69,000 7,777 Mar 24, 2017, 04:24 PM
Bodick Neil Chief Medical Officer Mar 17, 2017 Sale $20.41 5,000 102,038 50,937 Mar 20, 2017, 07:42 PM
Bodick Neil Chief Medical Officer Feb 24, 2017 Sale $19.15 5,000 95,758 55,937 Feb 27, 2017, 04:17 PM
Bodick Neil Chief Medical Officer Jan 20, 2017 Sale $18.35 5,000 91,747 60,937 Jan 23, 2017, 07:10 PM
DRISCOLL FREDERICK W Chief Financial Officer Dec 20, 2016 Option Exercise $9.01 1,134 10,217 10,531 Dec 27, 2016, 05:00 PM
Clayman Michael D. President and CEO Dec 20, 2016 Option Exercise $9.01 147 1,324 30,868 Dec 27, 2016, 04:58 PM
Bodick Neil Chief Medical Officer Dec 21, 2016 Sale $18.46 10,000 184,628 65,937 Dec 22, 2016, 04:40 PM
COLELLA SAMUEL D Director Dec 01, 2016 Buy $16.38 10,000 163,807 43,333 Dec 05, 2016, 02:40 PM
Clayman Michael D. President and CEO Nov 23, 2016 Buy $18.41 1,667 30,688 30,721 Nov 23, 2016, 08:17 PM
Clayman Michael D. President and CEO Nov 22, 2016 Buy $17.95 1,666 29,900 29,054 Nov 23, 2016, 08:35 AM
COLELLA SAMUEL D Director Nov 21, 2016 Buy $18.00 33,333 599,994 33,333 Nov 22, 2016, 06:40 PM
Clayman Michael D. President and CEO Nov 21, 2016 Buy $17.90 1,666 29,827 27,388 Nov 22, 2016, 02:28 PM
COLELLA SAMUEL D Director Jun 21, 2016 Buy $13.66 18,726 255,766 25,504 Jun 22, 2016, 01:36 PM
COLELLA SAMUEL D Director Jun 20, 2016 Buy $13.84 6,778 93,833 6,778 Jun 22, 2016, 01:36 PM
MERRIFIELD C ANN Director Jun 14, 2016 Buy $13.39 1,000 13,387 2,000 Jun 16, 2016, 05:59 PM
LUBASH BARBARA N 10% Owner Jun 08, 2016 Buy $14.00 714,285 9,999,990 3,511,670 Jun 10, 2016, 09:40 PM
Versant Ventures III, LLC 10% Owner Jun 08, 2016 Buy $14.00 714,285 9,999,990 3,511,670 Jun 10, 2016, 09:16 PM
COLELLA SAMUEL D Director Jun 08, 2016 Buy $14.00 714,285 9,999,990 3,511,670 Jun 10, 2016, 08:25 PM
Clayman Michael D. President and CEO May 23, 2016 Option Exercise $0.16 10,369 1,686 25,722 May 24, 2016, 05:26 PM
DRISCOLL FREDERICK W Chief Financial Officer May 20, 2016 Option Exercise $8.92 963 8,590 9,397 May 24, 2016, 05:25 PM
Clayman Michael D. President and CEO May 20, 2016 Buy $10.41 2,000 20,810 13,568 May 23, 2016, 04:04 PM
Clayman Michael D. President and CEO May 19, 2016 Buy $9.65 2,000 19,297 11,568 May 20, 2016, 05:52 PM
Bodick Neil Chief Medical Officer May 19, 2016 Buy $10.00 850 8,500 75,937 May 20, 2016, 05:51 PM
Clayman Michael D. President and CEO May 18, 2016 Buy $10.23 2,000 20,465 9,568 May 19, 2016, 05:30 PM
Bodick Neil Chief Medical Officer May 18, 2016 Buy $10.20 2,100 21,420 75,087 May 19, 2016, 05:29 PM
DRISCOLL FREDERICK W Chief Financial Officer May 17, 2016 Buy $9.87 2,500 24,668 8,434 May 18, 2016, 05:23 PM
Clayman Michael D. President and CEO May 17, 2016 Buy $9.73 2,000 19,465 7,568 May 18, 2016, 05:22 PM
Bodick Neil Chief Medical Officer May 17, 2016 Buy $9.60 800 7,680 72,987 May 18, 2016, 05:21 PM
DRISCOLL FREDERICK W Chief Financial Officer May 16, 2016 Buy $9.19 2,500 22,972 5,934 May 17, 2016, 06:12 PM
Clayman Michael D. President and CEO May 16, 2016 Buy $9.51 2,000 19,025 5,568 May 17, 2016, 06:10 PM
Bodick Neil Chief Medical Officer May 16, 2016 Buy $9.22 1,250 11,525 72,187 May 17, 2016, 06:08 PM
MERRIFIELD C ANN Director Sep 11, 2015 Buy $23.00 1,000 23,000 1,000 Sep 14, 2015, 04:32 PM
Novo A/S 10% Owner Jun 18, 2015 Sale $21.51 35,700 767,903 2,247,431 Jun 22, 2015, 06:22 PM
Novo A/S 10% Owner Jun 22, 2015 Sale $20.55 63,412 1,302,844 2,133,131 Jun 22, 2015, 06:22 PM
Novo A/S 10% Owner Jun 19, 2015 Sale $20.07 50,888 1,021,225 2,196,543 Jun 22, 2015, 06:22 PM
DRISCOLL FREDERICK W Chief Financial Officer May 20, 2015 Option Exercise $11.91 1,311 15,614 2,754 May 27, 2015, 03:10 PM
Clayman Michael D. President and CEO May 20, 2015 Option Exercise $11.91 1,784 21,247 282,229 May 27, 2015, 03:07 PM
Clayman Michael D. President and CEO Mar 24, 2015 Option Exercise $0.16 5,000 813 280,445 Mar 25, 2015, 04:01 PM
Bodick Neil Chief Medical Officer Mar 16, 2015 Sale $25.28 4,000 101,115 72,437 Mar 16, 2015, 05:19 PM
Bodick Neil Chief Medical Officer Mar 10, 2015 Sale $24.26 4,000 97,055 74,937 Mar 11, 2015, 02:22 PM
Bodick Neil Chief Medical Officer Mar 04, 2015 Sale $23.45 4,000 93,790 78,937 Mar 05, 2015, 08:50 PM
Bodick Neil Chief Medical Officer Feb 26, 2015 Sale $22.44 4,000 89,766 82,937 Feb 26, 2015, 08:25 PM
Sofinnova Partners SAS 10% Owner Oct 29, 2014 Sale $20.00 10,000 200,000 2,095,491 Jan 22, 2015, 02:02 PM
Novo A/S 10% Owner Dec 17, 2014 Buy $17.00 500,000 8,500,000 2,283,131 Dec 18, 2014, 03:44 PM
DRISCOLL FREDERICK W Chief Financial Officer Nov 20, 2014 Option Exercise $11.91 1,443 17,186 1,443 Nov 26, 2014, 05:16 PM
Clayman Michael D. President and CEO Nov 20, 2014 Option Exercise $11.91 1,784 21,247 275,445 Nov 26, 2014, 05:15 PM
Versant Venture Capital III, L.P. Director Sep 10, 2014 Option Exercise $17.61 2,250 39,623 2,250 Sep 12, 2014, 09:00 PM
Versant Venture Capital III, L.P. Director Sep 10, 2014 Option Exercise $17.61 2,250 39,623 2,250 Sep 12, 2014, 08:13 PM
Novo A/S 10% Owner Feb 18, 2014 Buy $13.00 692,308 9,000,004 1,783,131 Feb 20, 2014, 05:11 PM
Versant Venture Capital III, L.P. 10% Owner Feb 18, 2014 Buy $13.00 1,806 23,478 3,206,807 Feb 20, 2014, 03:01 PM
Versant Venture Capital III, L.P. 10% Owner Feb 18, 2014 Buy $13.00 305,886 3,976,518 3,205,001 Feb 20, 2014, 03:01 PM
Tordjman Rafael Director Feb 18, 2014 Buy $13.00 230,769 2,999,997 2,105,491 Feb 20, 2014, 03:00 PM
Sofinnova Partners SAS 10% Owner Feb 18, 2014 Buy $13.00 230,769 2,999,997 2,105,491 Feb 20, 2014, 02:59 PM
COLELLA SAMUEL D Director Feb 18, 2014 Buy $13.00 307,692 3,999,996 3,206,807 Feb 20, 2014, 02:50 PM
Bolzon Bradley J PhD Director Feb 18, 2014 Buy $13.00 307,692 3,999,996 3,206,807 Feb 20, 2014, 02:46 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Stejbach Mark Director 11/19/2021 107,364
MILINAZZO ALAN Director 11/19/2021 233,325
MERRIFIELD C ANN Director 11/19/2021 161,500
Lukatch Heath Director 11/19/2021 76,500
Kwo Elizabeth Director 11/19/2021 38,250
COLELLA SAMUEL D Director 11/19/2021 8,016
COLELLA SAMUEL D Director 11/19/2021 8,500
COLELLA SAMUEL D Director 11/19/2021 3,303,806
COLELLA SAMUEL D Director 11/19/2021 76,500
COLELLA SAMUEL D Director 11/19/2021 49,904
COLELLA SAMUEL D Director 11/19/2021 8,450,097
COLELLA SAMUEL D Director 11/19/2021 2,125
COLELLA SAMUEL D Director 11/19/2021 42,500
COLELLA SAMUEL D Director 11/19/2021 167,051
COLELLA SAMUEL D Director 11/19/2021 612,298
Canute Scott A Director 11/19/2021 76,500
MAHAFFY PATRICK J Director 11/19/2021 338,504
Levine Mark S. General Counsel 11/19/2021 1,134,631
Muzikant Adam Chief Business Officer 11/19/2021 881,161
Wentworth Kerry Chief Regulatory Officer 11/19/2021 51,000
Wentworth Kerry Chief Regulatory Officer 11/19/2021 1,197,166
Layman Melissa Chief Commercial Officer 11/19/2021 883,626
Willwerth Christina Chief Strategy Officer 11/19/2021 1,200,549
DRISCOLL FREDERICK W Chief Financial Officer 11/19/2021 260,780
Andrews William T. Chief Medical Officer 11/19/2021 291,125
Clayman Michael D. President and CEO 11/19/2021 209,100
Clayman Michael D. President and CEO 11/19/2021 3,177,037
Clayman Michael D. President and CEO 11/19/2021 2,851,733
Clayman Michael D. President and CEO 11/19/2021 3,303,806
Willwerth Christina Chief Strategy Officer 07/19/2021 25,445
Wentworth Kerry Chief Regulatory Officer 07/19/2021 25,439
Muzikant Adam Chief Business Officer 07/19/2021 12,061
Levine Mark S. General Counsel 07/19/2021 25,445
Muzikant Adam Chief Business Officer 06/21/2021 16,190
Wentworth Kerry Chief Regulatory Officer 06/21/2021 4,193
Clayman Michael D. President and CEO 06/21/2021 13,226
Arkowitz David Chief Financial Officer 05/10/2021 16,116
Layman Melissa Chief Commercial Officer 03/15/2021 53,336
Layman Melissa Chief Commercial Officer 01/28/2021 32,931
Clayman Michael D. President and CEO 01/28/2021 108,559
Muzikant Adam Chief Business Officer 01/05/2021 44,576
KELLEY SCOTT Chief Medical Officer 01/05/2021 76,007
Wentworth Kerry Chief Regulatory Officer 01/05/2021 76,007
Willwerth Christina Chief Strategy Officer 01/05/2021 73,480
Levine Mark S. General Counsel 01/05/2021 76,007
Arkowitz David Chief Financial Officer 01/05/2021 67,592
MILINAZZO ALAN Director 07/09/2020 40,500
Arkowitz David Chief Financial Officer 06/22/2020 14,111
Clayman Michael D. President and CEO 06/22/2020 14,111
KELLEY SCOTT Chief Medical Officer 06/22/2020 6,444
Levine Mark S. General Counsel 06/22/2020 11,079
Wentworth Kerry Chief Regulatory Officer 06/22/2020 3,996
Stejbach Mark Director 05/26/2020 19,997
Clayman Michael D. President and CEO 05/26/2020 99,996
Arkowitz David Chief Financial Officer 05/07/2020 26,253
Willwerth Christina Chief Strategy Officer 10/07/2019 14,008
Wentworth Kerry Chief Regulatory Officer 10/07/2019 14,008
Clayman Michael D. President and CEO 10/07/2019 61,540
KELLEY SCOTT Chief Medical Officer 10/07/2019 4,669
Bodick Neil Chief Scientific Officer 10/07/2019 18,817
MAHAFFY PATRICK J Director 08/29/2019 4,932
Willwerth Christina Chief Strategy Officer 08/13/2019 1,400
COLELLA SAMUEL D Director 08/08/2019 21,480
Clayman Michael D. President and CEO 08/08/2019 25,136
Clayman Michael D. President and CEO 06/21/2019 14,637
Levine Mark S. General Counsel 06/21/2019 11,900
Wentworth Kerry Chief Regulatory Officer 06/21/2019 3,816
KELLEY SCOTT Chief Medical Officer 06/21/2019 21,111
Arkowitz David Chief Financial Officer 06/21/2019 21,111
Arkowitz David Chief Financial Officer 05/31/2019 27,627
MERRIFIELD C ANN Director 05/23/2019 101,120
Arkowitz David Chief Financial Officer 05/13/2019 47,960
Clayman Michael D. President and CEO 05/10/2019 50,067
Arkowitz David Chief Financial Officer 05/08/2019 22,615
Clayman Michael D. President and CEO 03/12/2019 50,009
Wentworth Kerry Chief Regulatory Officer 10/08/2018 18,637
Levine Mark S. General Counsel 01/03/2019 9,072
Wentworth Kerry Chief Regulatory Officer 01/03/2019 7,688
KELLEY SCOTT Chief Medical Officer 01/03/2019 7,688
Arkowitz David Chief Financial Officer 12/20/2018 9,663
Bodick Neil Chief Scientific Officer 01/03/2019 9,221
Clayman Michael D. President and CEO 01/03/2019 40,516
Clayman Michael D. President and CEO 11/09/2018 85,477
Arkowitz David Chief Financial Officer 11/09/2018 66,222
Bodick Neil Chief Scientific Officer 10/08/2018 25,017
Clayman Michael D. President and CEO 10/08/2018 115,934
Wentworth Kerry Chief Regulatory Officer 10/08/2018 18,637
Arkowitz David Chief Financial Officer 08/09/2018 93,680
Clayman Michael D. President and CEO 08/09/2018 223,300
Bodick Neil Chief Scientific Officer 07/03/2018 412,300
Bodick Neil Chief Scientific Officer 07/02/2018 841,192
Wentworth Kerry Chief Regulatory Officer 06/20/2018 3,629
KELLEY SCOTT Chief Medical Officer 06/20/2018 21,241
Clayman Michael D. President and CEO 06/20/2018 11,756
Levine Mark S. General Counsel 06/20/2018 11,438
Bodick Neil Chief Scientific Officer 05/11/2018 6,130
Clayman Michael D. President and CEO 12/20/2017 2,754
KELLEY SCOTT Chief Medical Officer 12/20/2017 14,234
Bodick Neil Chief Scientific Officer 11/21/2017 24,656
Bodick Neil Chief Scientific Officer 11/21/2017 41,457
Clayman Michael D. President and CEO 11/08/2017 118,000
Bodick Neil Chief Scientific Officer 10/06/2017 47,835
Clayman Michael D. President and CEO 10/06/2017 173,443
Deniz Yamo Chief Medical Officer 09/05/2017 24,200
Deniz Yamo Chief Medical Officer 09/01/2017 72,450
Deniz Yamo Chief Medical Officer 08/31/2017 34,925
Clayman Michael D. President and CEO 06/20/2017 19,105
Stejbach Mark Director 06/16/2017 26,888
COLELLA SAMUEL D Director 06/05/2017 85,048
Clayman Michael D. President and CEO 06/05/2017 86,152
Bodick Neil Chief Medical Officer 05/15/2017 17,214
Bodick Neil Chief Medical Officer 05/15/2017 129,448
Bodick Neil Chief Medical Officer 04/17/2017 12,601
Bodick Neil Chief Medical Officer 04/17/2017 141,132
Bodick Neil Chief Medical Officer 03/17/2017 12,601
Bodick Neil Chief Medical Officer 03/17/2017 102,038
Bodick Neil Chief Medical Officer 02/24/2017 10,081
Bodick Neil Chief Medical Officer 02/24/2017 95,758
Bodick Neil Chief Medical Officer 05/15/2017 129,448
Bodick Neil Chief Medical Officer 04/17/2017 141,132
DRISCOLL FREDERICK W Chief Financial Officer 03/23/2017 23,658
DRISCOLL FREDERICK W Chief Financial Officer 03/23/2017 69,000
Bodick Neil Chief Medical Officer 03/17/2017 102,038
Bodick Neil Chief Medical Officer 02/24/2017 95,758
Bodick Neil Chief Medical Officer 01/20/2017 91,747
DRISCOLL FREDERICK W Chief Financial Officer 12/20/2016 10,217
Clayman Michael D. President and CEO 12/20/2016 1,324
Bodick Neil Chief Medical Officer 12/21/2016 184,628
COLELLA SAMUEL D Director 12/01/2016 163,807
Clayman Michael D. President and CEO 11/23/2016 30,688
Clayman Michael D. President and CEO 11/22/2016 29,900
COLELLA SAMUEL D Director 11/21/2016 599,994
Clayman Michael D. President and CEO 11/21/2016 29,827
COLELLA SAMUEL D Director 06/21/2016 255,766
COLELLA SAMUEL D Director 06/20/2016 93,833
MERRIFIELD C ANN Director 06/14/2016 13,387
LUBASH BARBARA N 10% Owner 06/08/2016 9,999,990
Versant Ventures III, LLC 10% Owner 06/08/2016 9,999,990
COLELLA SAMUEL D Director 06/08/2016 9,999,990
Clayman Michael D. President and CEO 05/23/2016 1,686
DRISCOLL FREDERICK W Chief Financial Officer 05/20/2016 8,590
Clayman Michael D. President and CEO 05/20/2016 20,810
Clayman Michael D. President and CEO 05/19/2016 19,297
Bodick Neil Chief Medical Officer 05/19/2016 8,500
Clayman Michael D. President and CEO 05/18/2016 20,465
Bodick Neil Chief Medical Officer 05/18/2016 21,420
DRISCOLL FREDERICK W Chief Financial Officer 05/17/2016 24,668
Clayman Michael D. President and CEO 05/17/2016 19,465
Bodick Neil Chief Medical Officer 05/17/2016 7,680
DRISCOLL FREDERICK W Chief Financial Officer 05/16/2016 22,972
Clayman Michael D. President and CEO 05/16/2016 19,025
Bodick Neil Chief Medical Officer 05/16/2016 11,525
MERRIFIELD C ANN Director 09/11/2015 23,000
Novo A/S 10% Owner 06/18/2015 767,903
Novo A/S 10% Owner 06/22/2015 1,302,844
Novo A/S 10% Owner 06/19/2015 1,021,225
DRISCOLL FREDERICK W Chief Financial Officer 05/20/2015 15,614
Clayman Michael D. President and CEO 05/20/2015 21,247
Clayman Michael D. President and CEO 03/24/2015 813
Bodick Neil Chief Medical Officer 03/16/2015 101,115
Bodick Neil Chief Medical Officer 03/10/2015 97,055
Bodick Neil Chief Medical Officer 03/04/2015 93,790
Bodick Neil Chief Medical Officer 02/26/2015 89,766
Sofinnova Partners SAS 10% Owner 10/29/2014 200,000
Novo A/S 10% Owner 12/17/2014 8,500,000
DRISCOLL FREDERICK W Chief Financial Officer 11/20/2014 17,186
Clayman Michael D. President and CEO 11/20/2014 21,247
Versant Venture Capital III, L.P. Director 09/10/2014 39,623
Versant Venture Capital III, L.P. Director 09/10/2014 39,623
Novo A/S 10% Owner 02/18/2014 9,000,004
Versant Venture Capital III, L.P. 10% Owner 02/18/2014 23,478
Versant Venture Capital III, L.P. 10% Owner 02/18/2014 3,976,518
Tordjman Rafael Director 02/18/2014 2,999,997
Sofinnova Partners SAS 10% Owner 02/18/2014 2,999,997
COLELLA SAMUEL D Director 02/18/2014 3,999,996
Bolzon Bradley J PhD Director 02/18/2014 3,999,996
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2021
12/31/2020
10.73%
1Q
03/31/2021
12/31/2019
30.86%
5Q

Period of Report: 03/31/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2020
10.73%
1Q
12/31/2019
30.86%
5Q